Survey on the use of molecular targeted drugs for advanced hepatocellular carcinoma.
Not Applicable
Recruiting
- Conditions
- hepatocellular carcinoma
- Registration Number
- JPRN-UMIN000050223
- Lead Sponsor
- Other
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who indicated their intention not to participate in the study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method After identifying patient selection and exclusion criteria, patients will be enrolled and observed until withdrawal of consent, patient death, last hospital visit (loss to follow-up) or end of study period (one year after last enrolled case). Safety will be investigated during this observation period.
- Secondary Outcome Measures
Name Time Method Investigate patient background, treatment, efficacy and patient outcomes.